They may note a mottled appearance caused by pigmentary changes in the macula. In the early stage of macular degeneration, your healthcare provider may find drusen. These are yellow-colored deposits ...

A study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet ...

Age-related macular degeneration can have severe effects, but treatments for the condition are available. (Getty Images) Have your parents or grandparents ever had trouble driving, reading or ...

A device that beams light into the eyes can improve the sight of people with a leading form of vision loss, known as ...

Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...

Australian scientists have successfully used an innovative gene therapy technique in the lab to combat a key cause of vision ...

Curcuma-based nutritional supplements (CBNS) have been scientifically established to possess antioxidant and ...

Reduced well-being and loss of productivity were contributors to the high economic burden in patients with late-stage age-related macular degeneration (AMD) living in the US, Germany, and Bulgaria.

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, has presented new data on its lead ...

HuidaGene Therapeutics (HuidaGene), a global clinical-stage biotechnology company developing genome medicines, announced that the US FDA has cleared its HG202 investigational new drug (IND) ...

HG202 is the first CRISPR/Cas13Y RNA-targeting therapy to enter clinical development and the only clinical-stage CRISPR RNA-editing therapy for age-related macular degeneration Preclinical studies in ...